Adolescent and young adult cancer survival

Journal of the National Cancer Institute - Monographs

Volumn 2014, Issue 49, 2014, Pages 228-235

  Lewis, Denise Riedel ^a   Seibel, Nita L ^a   Smith, Ashley Wilder ^a   Stedman, Margaret R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COLON CARCINOMA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; FEMALE; GERM CELL TUMOR; HIGH RISK PATIENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEWBORN; NONHODGKIN LYMPHOMA; NUCLEOPHOSMIN 1 GENE; OSTEOSARCOMA; PRIORITY JOURNAL; RECTUM CARCINOMA; SENESCENCE; SKIN CARCINOMA; SOFT TISSUE SARCOMA; SURVIVAL RATE; THYROID CARCINOMA; TROPHOBLASTIC TUMOR; TUMOR GENE; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA; YOUNG ADULT; GENETICS; HEALTH SERVICE; MORTALITY; NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; NEOPLASMS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84937725648     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgu019     Document Type: Article

References (38)

1. SEER*Stat Database: SEER-18 November 2012 Katrina Rita Adjustment. Bethesda, MD: National Cancer Institute; 2012. http://seer.cancer.gov. Accessed September 9, 2014.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30.
3. Bleyer A,Barr R, Hayes-Lattin B, et al. The distinctive biology of cancer in adolescents and young adults. Nature. 2008;8:288-298.
4. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer. Cancer. 2006;107(7 suppl):1645-1655.
5. LIVESTRONG Young Adult Alliance Steering Committee. Closing the gap: a strategic plan: addressing the recommendations of the Adolescent and Young Adult Oncology Progress Review Group. http://www.livestrong.org/pdfs/LAF-YAA-Report-pdf. Published 2006. Accessed September 10, 2014.
6. Tricoli JV, Seibel NL, Blair DG, Albritton K, Hayes-Lattin B. Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst. 2011;103(8):628-635.
7. Barr R, Bleyer A, Eds. Impact of Malignant Disease on Young Adults. Seminars in oncology. 2009;36(3 (Part I) and 5 (Part II)):A1-A6,191-288; A1-A10, 373-490.
8. Keegan TH, Tao L, DeRouen MC, et al.; AYA HOPE Study Collaborative Group. Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv. 2014;8(2):282-292.
9. Aizer AA, Falit B, Mendu ML, et al. Cancer-specific outcomes among young adults without health insurance. J Clin Oncol. 2014; 32:2025-2030. doi:10.1200/JCO.2013.54.2555.
10. Harrison CJ, Martineau M, Secker-Walker LM. The Leukaemia research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol. 2001;113(1):3-10.
11. Majhail NS, Brazauskas R, Hassebroek A, et al. Outcomes of allogeneic heamtopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia. Biol Blood Marrow Transplant. 2012;18:861-873.
12. Guy GP, Yabroff R, Ekwueme DU, et al. Estimating the health and economic burden of cancer among those diagnosed as adolescents and young adults. Health Affairs. 2014;33(6):1024-1031.
13. Kwak M, Zebrack B, Meeske KA, et al. Prevalence and predictors of posttraumatic stress symptoms in adolescent and young adult cancer survivors: a 1-year follow-up study. Psycho-Oncology. 2013;22:1798-1806.
14. Barr RD, Holowaty EJ, Birch JM. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer. 2006;106(7):1425-1430.
15. World Health Organization. International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland; 2000.
16. Howlader N, Ries LA, Mariotto AB, et al. Improved estimates of cancerspecific survival rates from population-based data. J Natl Cancer Inst. 2010;102(20):1584-1598.
17. Shambaugh EM WM, Axtell LM (eds). Summary Staging Guide. US Department of Health, Education, and Welfare, Pubic Health Service, National Institutes of Health; 1977.
18. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M, Eds. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 6th edition. New York: Springer-Verlag, 2002.
19. Swerdlow SH, Campo, E, Harris NL, et al., eds. Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008.
20. Ruhl J, Adamo M, Dickie L, Sun L, eds. Hematopoietic and Lymphoid Neoplasms Case Reportability and Coding Manual. Bethesda, MD: National Cancer Institute; 2012. http://seer.cancer.gov/tools/heme/Hematopoietic_Instructions_and_Rules.pdf. Accessed July 31, 2013.
21. Documentation for the expected survival life tables. Surveillance Epidemiology, and End Results Program Web site. http://seer.cancer.gov/expsurvival/documentation.html. Accessed September 8, 2014.
22. Yu B, Tiwari RC, Cronin KA, McDonald C, Feuer EJ. CANSURV: a Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed. 2005;80(3):195-203.
23. Howlader N, Noone AM, Krapcho M, et al, eds. Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
24. Pinsky PF, Miller A, Kramer BS, et al. Evidence of a healthy volunteer effect in the Prostate, Lung, Colorectal, and Ovarian Screening Trial. Am J Epidemiol. 2007;165(8):874-881.
25. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97(1):134-147.
26. Yabroff KR, Harlan LC, Clegg LX, et al. Is mode of breast cancer detection associated with cancer treatment in the United States? Cancer. 2008;112(5):1011-1019.
27. Johnson RH, Chien FL, Bleyer A. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013;309(8):800-805.
28. Schlenk RF, Döhner K, Krauter J, et al.; German-Austrian Acute Myeloid Leukemia Study Group. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med. 2008;358(18):1909-1918.
29. Advani AS, Hunger SP, Burnett AK. Acute leukemia in adolescents and young adults. Semin Oncol. 2009;36(3):213-226.
30. Ross DS. Predicting outcome in patients with thyroid cancer. J Clin Endocrinol Metab. 2013;98(12):4673-4675.
31. Pathak K, Mazurat A, Lambert P, Klonisch T, Nason RW. Prognostic nomograms to predict oncological outcome of thyroid cancers. J Clin Endcrinol Metab. 2013;98:4768-4775.
32. Jaglowski SM, Linden E, Termuhlen AM, Flynn JM. Lymphoma in adolescents and young adults. Semin Oncol. 2009;36:381-418.
33. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2013.
34. Plym A, Ullenhag G, Breivald M, Lambe M, Berglund A. Clinical characteristics, management and survival in young adults diagnosed with malignant melanoma: A population-based cohort study. Acta Oncologica. 2014;53:688-696.
35. Cost NG. Testicular germ cell tumors. Current concepts and management strategies. Minerva Urol Nefrol. 2013;65(2):133-155.
36. Harlan LC, Lynch CF, Keegan TH, et al.; AYA HOPE Study Collaborative Group. Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv. 2011;5(3):305-314.
37. Pinheiro PS, Liu L, Bungum TJ, Altekruse SF. The impact of follow-up type and missed deaths on population-based cancer survival studies for Hispanics and Asians. J Natl Cancer Inst Monogr. 2014;49:210-217.
38. Roberts KG, Payne-Turner D, Pei D, et al. Integrated genomic and mutational profiling of adolescent and young adult ALL identifies a high frequency of BCR-ABL1-like ALL with very poor outcome. Paper presented at: 55th Annual American Society of Hematology Meeting; December 7-10, 2013; New Orleans, LA.